In collaboration with @CRISPRTx, we announced new data at the @ASH_hematology Annual Meeting for our investigational gene-editing program for the treatment of sickle cell disease and beta thalassemia, and a @NEJM publication on this program. https://t.co/hn8ke07auA #ASH20